Latest Period
Q1 2026
Security Snapshot
Astrana Health, Inc. - Common Stock (ASTH) Institutional Ownership
CUSIP: 03763A207
13F Institutional Holders and Ownership History from Q4 2017 to Q1 2026
Institutions Reporting
170
Shares (Excl. Options)
29,910,654
Price
$24.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ASTH on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 29,910,654
- Total 13F value
- $733,415,048
- Portfolio coverage rank
- 0%
- Share change
- +658,035
- Value change
- +$14,458,237
- Number of holders
- 170
- Shares outstanding
- 50,156,118
- SEC-reported price per share
- $37.97
- Insider filing price
- $37.97
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ASTH - Astrana Health, Inc. - Common Stock is tracked under CUSIP 03763A207.
- 170 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 174 to 170 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $724,380,671 to $733,415,048.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 170 institutions filings for Q1 2026.
Security key
03763A207
Latest holder period
Q1 2026
13F holders
170
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
ASTH full holder history
Astrana Health, Inc. SEC filings
Astrana Health, Inc. company facts
Astrana Health, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03763A207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
ASTH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | +9.1% | $191,646,870 | -$6,109,882 | 6,234,446 | -3.1% | BlackRock, Inc. | 31 Mar 2025 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 11% | -10% | $188,522,333 | -$21,514,803 | 6,132,802 | -10% | Allied Physicians of California, a Professional Medical Corporation | 15 Feb 2025 |
As of 31 Mar 2026, 170 institutional investors reported holding 29,910,654 shares of Astrana Health, Inc. - Common Stock (ASTH). This represents 60% of the company’s total 50,156,118 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
50%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 6,163,727 | +0.1% | 0% | $151,134,593 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5% | 2,276,806 | 0% | 0% | $55,827,283 |
| 325 CAPITAL LLC | 3.7% | 1,839,076 | 0% | 16% | $45,094,144 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 1,710,262 | 0% | 0% | $41,935,624 |
| STATE STREET CORP | 3.3% | 1,650,490 | -1.5% | 0% | $40,470,015 |
| DIMENSIONAL FUND ADVISORS LP | 2.7% | 1,368,079 | +13% | 0.01% | $33,544,621 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.7% | 1,341,824 | +82% | 0.01% | $32,901,525 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 1,038,085 | +0.96% | 0% | $25,458,709 |
| 683 Capital Management, LLC | 1.4% | 700,000 | 1.6% | $17,164,000 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.3% | 644,171 | +17% | 0% | $15,795,073 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 574,729 | +13% | 0% | $14,092,355 |
| SteelPeak Wealth, LLC | 1.1% | 559,937 | -3.4% | 0.43% | $13,729,656 |
| AMERIPRISE FINANCIAL INC | 1.1% | 551,599 | +26% | 0% | $13,525,207 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | 1.1% | 544,034 | +26% | 0.08% | $13,339,714 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 0.96% | 481,520 | +15% | 0.04% | $11,806,870 |
| NORTHERN TRUST CORP | 0.87% | 438,163 | +8.9% | 0% | $10,743,758 |
| FMR LLC | 0.83% | 416,125 | -61% | 0% | $10,203,392 |
| ROYCE & ASSOCIATES LP | 0.79% | 396,961 | +14% | 0.1% | $9,733,484 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.77% | 386,424 | -18% | 0.04% | $9,475,116 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.7% | 351,630 | +15% | 0.01% | $8,621,967 |
| Invesco Ltd. | 0.7% | 351,112 | -1.2% | 0% | $8,609,266 |
| MORGAN STANLEY | 0.68% | 338,803 | -22% | 0% | $8,307,470 |
| LPL Financial LLC | 0.62% | 309,125 | 0% | 0% | $7,579,745 |
| UBS Group AG | 0.6% | 301,926 | +71% | 0% | $7,403,225 |
| GOLDMAN SACHS GROUP INC | 0.59% | 295,329 | -6.2% | 0% | $7,241,467 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
34
Latest
Q1 2026
Rows shown
1-25 of 34
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 29,910,654 | $733,415,048 | +$14,458,237 | $24.52 | 170 |
| 2025 Q4 | 29,137,341 | $724,380,671 | +$62,743,872 | $24.81 | 174 |
| 2025 Q3 | 26,741,841 | $759,043,836 | +$22,746,916 | $28.35 | 186 |
| 2025 Q2 | 25,772,189 | $641,392,329 | -$15,342,979 | $24.88 | 161 |
| 2025 Q1 | 26,257,633 | $814,637,036 | +$5,862,823 | $31.01 | 168 |
| 2024 Q4 | 26,057,927 | $822,017,819 | +$3,128,832 | $31.53 | 177 |
| 2024 Q3 | 25,295,709 | $1,465,673,353 | +$131,700,353 | $57.94 | 186 |
| 2024 Q2 | 23,072,576 | $935,815,210 | +$22,763,995 | $40.56 | 169 |
| 2024 Q1 | 22,756,494 | $955,393,465 | +$24,413,741 | $41.99 | 158 |
| 2023 Q4 | 22,178,838 | $849,210,903 | +$26,256,665 | $38.30 | 141 |
| 2023 Q3 | 21,503,159 | $663,623,547 | +$22,662,738 | $30.85 | 132 |
| 2023 Q2 | 20,757,071 | $656,229,537 | +$22,212,849 | $31.60 | 129 |
| 2023 Q1 | 20,034,782 | $730,631,066 | +$14,461,853 | $36.47 | 131 |
| 2022 Q4 | 19,704,382 | $583,144,207 | -$13,404,604 | $29.59 | 129 |
| 2022 Q3 | 19,814,272 | $772,607,625 | +$70,014,740 | $39.00 | 148 |
| 2022 Q2 | 17,767,757 | $685,808,256 | +$18,274,263 | $38.59 | 126 |
| 2022 Q1 | 17,609,470 | $853,298,644 | +$10,418,988 | $48.47 | 129 |
| 2021 Q4 | 17,108,614 | $1,256,730,970 | +$26,349,379 | $73.48 | 140 |
| 2021 Q3 | 16,644,270 | $1,516,521,911 | +$595,571,146 | $91.05 | 137 |
| 2021 Q2 | 10,256,705 | $644,299,364 | +$260,959,544 | $62.81 | 102 |
| 2021 Q1 | 6,359,542 | $172,275,211 | +$32,027,527 | $27.09 | 75 |
| 2020 Q4 | 5,211,206 | $95,222,607 | +$2,906,278 | $18.27 | 60 |
| 2020 Q3 | 5,058,422 | $90,682,749 | +$15,496,005 | $17.94 | 62 |
| 2020 Q2 | 4,195,952 | $69,229,389 | +$12,105,432 | $16.50 | 49 |
| 2020 Q1 | 3,507,141 | $45,315,795 | -$1,124,491 | $12.92 | 49 |